Mirum Pharmaceuticals, Inc.
USD122.31
-0.69 (-0.56%)
CEO
Christopher Peetz
IPO Date
2019-07-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$122.90
Prev. Close
$123.00
Day Low
$121.13
Day High
$124.57
52W Low
$47.89
52W High
$125.39
Market Cap
$6.14B
Volume
0.06M
| -22.3 |
| 31 Dec 2023 | FY | 74.8% | -87.7% | -65.7% | -25.3% | 1.24 | 4.45 | -7.4 |
| 31 Dec 2022 | FY | 83.9% | -176.0% | -95.5% | -38.4% | 0.02 | 2.94 | -4.9 |
| 31 Dec 2021 | FY | 90.1% | -438.9% | -69.9% | -28.5% | 0.02 | 3.91 | -5.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -60.0% | -42.9% | 0.02 | 12.80 | -4.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -40.3% | -35.8% | 0.03 | 9.13 | -10.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 168.1% | -33.4% | 0.00 | 21.22 | -17.5 |
| -173.0 |
| 30 Sept 2025 | Q3 | 80.8% | 2.2% | 1.0% | 0.4% | 1.09 | 3.31 | 366.6 |
| 30 Jun 2025 | Q2 | 81.7% | -4.6% | -2.3% | -0.8% | 1.25 | 3.13 | -107.9 |
| 31 Mar 2025 | Q1 | 79.4% | -13.2% | -6.3% | -2.1% | 1.36 | 3.22 | -37.5 |
| 31 Dec 2024 | Q4 | 77.1% | -23.9% | -10.5% | -3.5% | 1.41 | 3.10 | -21.0 |
| 30 Sept 2024 | Q3 | 77.0% | -15.8% | -6.1% | -2.1% | 1.37 | 3.34 | -32.7 |
| 30 Jun 2024 | Q2 | 74.0% | -31.6% | -10.8% | -3.7% | 1.38 | 3.28 | -16.4 |
| 31 Mar 2024 | Q1 | 74.2% | -36.5% | -10.8% | -3.9% | 1.31 | 3.68 | -11.8 |
| 31 Dec 2023 | Q4 | 64.0% | -51.3% | -14.3% | -5.5% | 1.24 | 4.45 | -9.7 |